This compound is a pharmaceutical intermediate primarily used in the manufacturing of antihypertensive agents. It features a complex multi-ring structure with aromatic and heterocyclic components, and is supplied as a research-grade chemical for laboratory and development purposes.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 144690-33-5
Trityl olMesartan acid
Pharmaceutical intermediate for drug synthesis
Tritylolmesartan medoxomil
Pharmaceutical intermediate for olmesartan medoxomil
N-Trityl Olmesartan Ethyl Ester
pharmaceutical intermediate
P-(Chlorodiphenylmethyl)anisole
Pharmaceutical intermediate for oligonucleotide synthesis
Desacetyl-7-desmethyl Agomelatine Hydrobromide
Pharmaceutical intermediate for agomelatine synthesis
Methyl (2-chlorophenyl)(4,7-dihydrothieno(2,3-c)pyridin-6(5H)-yl)acetate--hydrogen chloride (1/1)
Clopidogrel impurity reference standard
N-Carbamoyl-2-cyanoacetamide
Pharmaceutical intermediate
(2-BUTYL-4-CHLORO-1-((2'-(1-TRITYL-1H-TETRAAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-1H-IMIDAZOL-5-YL)METHANOL
pharmaceutical impurity standard
ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(1-trityltetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate
TZQDBKJBKJIHPR-UHFFFAOYSA-N
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=NN4C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)C(=O)OCC)C(C)(C)O